MHRA-100092-PIP01-21-M01 (update)

Key Facts

Active Substance
Active Substance:
  • VENETOCLAX
Invented Name
Not yet available
PIP Number MHRA-100092-PIP01-21-M01 (update)
Pharmaceutical form(s)
  • Film-coated tablets
  • Tablet for oral suspension
Therapeutic area
Therapeutic area:
  • Oncology
Conditions / Indications
  • Haematopoietic and lymphoid malignant neoplasms
  • Treatment of solid tumour malignant neoplasms
Route(s) of administration
Route(s) of administration:
  • Oral use
PIP applicant
Decision Type
Decision Type
PM: decision on the application for modification of an agreed paediatric investigation plan.
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):VENETOCLAX.pdf
Published Date 03/12/2021